The Journal of Clinical Endocrinology & Metabolism· 2026Q1
Hedeflenen Sıcaklık Yönetimi Sırasında 12,13-diHOME Artar ve Kardiyak Arrest Resüsitasyonu Sonrası Hayatta Kalma ile İlişkilidir
12,13-diHOME is increased during targeted temperature management and correlates with survival after cardiac arrest resuscitation
- 1atıf
- Q1SCImago
- 2026yıl
Kısa özet
Kahverengi adipoz doku (BAT) aktivitesinin bir belirteci olan dolaşımdaki 12,13-diHOME seviyeleri, hedeflenen sıcaklık yönetimi (TTM) uygulanan bazı kardiyak arrest hastalarında yükselir ve daha iyi hayatta kalma ile ilişkilidir.
Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.
Ana noktalar
- 12,13-diHOME seviyeleri, 33°C'de TTM uygulanan kardiyak arrest hastalarında arttı.
- Yükselmiş 12,13-diHOME, olumlu sonuçlar ve hayatta kalma ile pozitif olarak ilişkiliydi.
- 12,13-diHOME seviyeleri 12-48 saat içinde zirveye ulaştı ve 7 günde azaldı.
- Daha yüksek 12,13-diHOME, spesifik bir fosfolipid imzası ve değişmiş nötrofil olgunlaşması ile ilişkilendirildi.
Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.
Özet (abstract)
CONTEXT: Trials of targeted temperature management (TTM) after cardiac arrest (CA) have had conflicting results. Brown adipose tissue (BAT) is a thermogenic organ activated by cold temperature to regulate body temperature, systemic metabolism and the immune system. Approximately 10-30% of adult patients have BAT and this heterogeneity may explain variable treatment to TTM. OBJECTIVE: This study sought to measure differences in outcome, metabolic and immune activation between patients treated with TTM following CA with varying BAT activity, measured through BAT-associated lipid 12,13-diHOME concentrations in circulation. DESIGN: BAT biomarker 12,13-diHOME was quantified using liquid chromatography-mass spectrometry (LC-MS) on plasma from 74 patients at various time points starting at 6 hours and up until 7 days after return of spontaneous circulation (ROSC). Additionally, circulating glucose, C-peptide and fatty acids were measured by glucometer, ELISA and LC-MS, respectively. Peripheral blood mononuclear cells were analyzed by flow cytometry. RESULTS: 12,13-diHOME was increased in patients treated with TTM at 33°C and positively correlated with favorable outcomes. 12,13-diHOME levels peaked in the first 12 to 48 hours and decreased below the first post-ROSC level by 7 days. Glucose homeostasis was not associated with 12,13-diHOME levels. In a subset of patients, we could detect a specific phospholipid signature in patients with higher 12,13-diHOME. Patients with higher 12,13-diHOME also had increased mature neutrophils and lower immature neutrophils. CONCLUSIONS: Circulating 12,13-diHOME levels are increased in some patients undergoing targeted temperature management after cardiac arrest, which may be indicative of increased BAT activity. 12,13-diHOME is associated with survival, alterations of phospholipid metabolism, and a profile of less activated immune system. BAT may mediate the effects of temperature management on outcome after cardiac arrest.
Yazarların özeti; kaynağından alınmıştır. The Journal of Clinical Endocrinology & Metabolism, 2026 · DOI ↗
Ücretsiz hesapla devam et
Makaleye Sor ile bu makaleye günde 3 soru ücretsiz; makaleyi kaydet, kaynakçasını al, ilgi alanına göre her gün yeni özetler. Çıkarımlar Premium.
Web'de ücretsiz devam etGoogle ya da Apple hesabınla giriş; kart istemez. Bu makaleye geri dönersin.
Telefonda:
Alan: Acil Tıp
Emergency MedicineMedicine